Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration

Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy

(2015) Florentia Peintinger et al.   MODERN PATHOLOGY

Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group

(2015) Elena Provenzano et al.   MODERN PATHOLOGY

Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy

(2014) A. Sheri et al.   ANNALS OF ONCOLOGY

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

(2014) Patricia Cortazar et al.   LANCET

Clinically Meaningful Tumor Reduction Rates Vary by Prechemotherapy MRI Phenotype and Tumor Subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

(2013) Rita A. Mukhtar et al.   ANNALS OF SURGICAL ONCOLOGY

Pathologic Response and Long-Term Follow-up in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Comparison Between Classifications and Their Practical Application

(2013) Adriana D. Corben et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer

(2013) G. von Minckwitz et al.   CLINICAL CANCER RESEARCH

Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer

(2013) Judy C. Boughey   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

An International Ki67 Reproducibility Study

(2013) Mei-Yin C. Polley et al.   JNCI-Journal of the National Cancer Institute

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

(2013) Thorsten Kuehn et al.   LANCET ONCOLOGY

Variability in hormone and growth factor receptor expression in primary versus recurrent, metastatic, and post-neoadjuvant breast carcinoma

(2012) Mark N. Jabbour et al.   BREAST CANCER RESEARCH AND TREATMENT

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

(2012) Gunter von Minckwitz et al.   JOURNAL OF CLINICAL ONCOLOGY

Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27

(2012) Eleftherios P. Mamounas et al.   JOURNAL OF CLINICAL ONCOLOGY

Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657

(2012) Laura J. Esserman et al.   JOURNAL OF CLINICAL ONCOLOGY

Preoperative Ultrasound-Guided Needle Biopsy of Axillary Nodes in Invasive Breast Cancer

(2011) Nehmat Houssami et al.   ANNALS OF SURGERY

Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer—results from the GeparQuattro study (GBG 40)

(2011) Gunter von Minckwitz et al.   BREAST CANCER RESEARCH AND TREATMENT

A novel automated assay for the rapid identification of metastatic breast carcinoma in sentinel lymph nodes

(2011) Sheldon Feldman et al.   CANCER

The Hormonal Receptor Status in Breast Cancer can be Altered by Neoadjuvant Chemotherapy: A Meta-Analysis

(2011) Ning Zhang et al.   CANCER INVESTIGATION

Accelerating Identification and Regulatory Approval of Investigational Cancer Drugs

(2011) Laura J. Esserman et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Validation of a Novel Staging System for Disease-Specific Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy

(2011) Elizabeth A. Mittendorf et al.   JOURNAL OF CLINICAL ONCOLOGY

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

(2011) M. Dowsett et al.   JNCI-Journal of the National Cancer Institute

Proposals for uniform collection of biospecimens from neoadjuvant breast cancer clinical trials: timing and specimen types

(2011) Sherene Loi et al.   LANCET ONCOLOGY

Estrogen and HER-2 Receptor Discordance Between Primary Breast Cancer and Metastasis

(2010) L. Pusztai et al.   ONCOLOGIST

Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes

(2009) E. A. Mittendorf et al.   CLINICAL CANCER RESEARCH

The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer

(2008) Robin L. Jones et al.   BREAST CANCER RESEARCH AND TREATMENT

Titanium clip placement to allow accurate tumour bed localisation following breast conserving surgery – Audit on behalf of the IMPORT Trial Management Group

(2008) C.E. Coles et al.   EJSO

Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer

(2008) Mike Visser et al.   INTERNATIONAL JOURNAL OF CANCER

Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27

(2008) Priya Rastogi et al.   JOURNAL OF CLINICAL ONCOLOGY

Outcome Prediction for Estrogen Receptor-Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics

(2008) M. J. Ellis et al.   JNCI-Journal of the National Cancer Institute